Citation Impact
Citing Papers
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
2017
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
2021 Standout
Microbiota in health and diseases
2022 Standout
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism
2017
From NASH to HCC: current concepts and future challenges
2019
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Sex differences in the association between perfluoroalkyl acids and liver function in US adolescents: Analyses of NHANES 2013–2016
2019
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Understanding Environmental Contaminants’ Direct Effects on Non-alcoholic Fatty Liver Disease Progression
2019
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
2020
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis
2022
Hallmarks of aging: An expanding universe
2023 Standout
Hepatocellular carcinoma
2021 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
2015
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
2018
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Non-alcoholic fatty liver disease
2021 Standout
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
2018
Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2017
Lipophagy and liver disease: New perspectives to better understanding and therapy
2017
Non-alcoholic fatty liver disease and the interface between primary and secondary care
2018
Apoptosis and necroptosis in the liver: a matter of life and death
2018
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity
2022
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Diet and exercise in NAFLD/NASH: Beyond the obvious
2021
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
2018
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
2019
Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives
2018
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
p62/SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
2016
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
2019
Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis
2018
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
2017
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
2019 Standout
Works of Elena Buzzetti being referenced
Gender differences in liver disease and the drug-dose gender gap
2017
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
2017
Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
2015
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)
2017
Interventions for hereditary haemochromatosis
2017
Pharmacological interventions for acute hepatitis B infection
2017
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
2021